Abiraterone Acetate Tablet, Film Coated
Product Images NDC 60505-4764

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Abiraterone Acetate (NDC 60505-4764). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (01)

Chemical structure diagram of abiraterone acetate showing its molecular configuration with labeled carbon, hydrogen, oxygen, and nitrogen atoms.*

FDA Label Image

Figure 1 (02)

A survival curve chart comparing the percentage of survival over time in months between two groups: one taking abiraterone acetate and the other a placebo. The horizontal axis represents time to death in months, and the vertical axis shows percentage survival. A legend differentiates the solid line for abiraterone acetate and the dashed line for placebo. The number of subjects at risk for each time point is displayed below the graph for both groups.*

FDA Label Image

Figure 2 (03)

A survival curve chart comparing abiraterone acetate and placebo over time. The x-axis shows months from randomization (0 to 60), and the y-axis represents the percentage of subjects without death (100% to 0%). Two lines depict survival probabilities for abiraterone acetate and placebo groups, with patient numbers at risk shown below the x-axis for both groups at different time points.*

FDA Label Image

Figure 3 (04)

A Kaplan-Meier survival plot comparing the percentage of subjects without radiographic progression or death over time for abiraterone acetate versus placebo. The x-axis shows months from randomization (0 to 18), while the y-axis shows the percentage of subjects without progression or death (0% to 100%). Two lines represent the groups: a solid line for abiraterone acetate and a dashed line for placebo, with numbers at risk displayed below the x-axis for both groups at various time points.*

FDA Label Image

Figure 4 (05)

A Kaplan-Meier survival curve graph showing the percentage of subjects without death over time in months from randomization. The graph compares survival between Abiraterone Acetate and Placebo groups, with the Abiraterone Acetate group demonstrating higher survival rates. A table below the x-axis shows the number of subjects at risk at various time points for both groups.*

FDA Label Image

Principal Display Panel (500 mg Tablet Bottle Label)

Label for Abiraterone Acetate Tablets, USP 500 mg, film-coated oral tablets. The label includes dosage storage instructions, manufacturer information (Qilu Pharmaceutical Co., Ltd., China), and labeler details (Apotex Corp., Weston FL, USA). It states the product contains 60 tablets with directions to swallow whole and not crush or chew. The label features the NDC 60505-4764-6 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.